MIAMI, FL--(MARKET WIRE)--Jun 4, 2007 -- DOR BioPharma, Inc. (OTC BB:DORB.OB - News) (“DOR,” or the “Company”), today announced that it will present at the 5th annual Biodefense Vaccines and Therapeutics Conference in Washington on Monday June 4th, 2007. Robert N. Brey, Ph.D., Chief Scientific Officer, will make a presentation at 2:15 PM entitled “Development and early clinical testing of a vaccine against ricin toxin” and will discuss the latest progress and developments concerning RiVax(TM). The conference is being held at the Almas Temple Club, 1315 K Street, Washington, DC. The conference addresses the development of countermeasures against significant biothreats and brings together scientific and policy leaders in the field.
